Newsfeeds Archive - Spark Newswire

4 minute read

Lucid Diagnostics Announces Peer-Reviewed Publication Of Data From National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study Of EsoGuard Esophageal Precancer Testing

May 2, 7:54 AM

EsoGuard demonstrated unprecedented early precancer detection, including 89% sensitivity at detecting short segment early precancer, the primary target of esophageal precancer testingPublication further strengthens

LUCD

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

April 30, 12:31 PM

Gainers Akili (NASDAQ:AKLI) stock moved upwards by 70.1% to $0.4 during Tuesday’s regular session. The company’s market cap…

AKLI

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights

April 29, 4:31 PM

Gainers GeneDx Hldgs (NASDAQ:WGS) shares increased by 21.8% to $13.4 during Monday’s after-market session. The market value of…

COSM

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights

February 19, 5:30 PM

Gainers Trxade Health (NASDAQ:MEDS) stock rose 105.3% to $8.5 during Monday’s after-market session. The company’s market cap stands…

DCTH

1 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

January 18, 9:05 AM

Gainers Celularity (NASDAQ:CELU) shares rose 43.4% to $0.27 during Thursday’s pre-market session. The company’s market cap stands at…

ADAG

3 minute read

Lucid Diagnostics Announces Peer-Reviewed Publication Of Results From Three Clinical Utility Studies; Studies Demonstrate Real-World Clinical Utility Of EsoGuard Testing To Detect Esophageal Precancer

By Benzinga Newsdesk

December 12, 9:31 AM

Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (NASDAQ:PAVM, PAVMZ)))) ( "PAVmed"),

LUCD

1 minute read

PAVmed Provides Additional Details For Upcoming Stock Dividend To Shareholders; PAVmed Shareholders As Of January 15, 2024 Will Participate In Distribution Of ~3.3M Shares Of Lucid Common Stock

By Benzinga Newsdesk

December 11, 10:18 AM

PAVmed shareholders as of January 15, 2024 will participate in distribution of approximately 3.3 million shares of Lucid common stockNEW YORK, Dec. 11, 2023 /PRNewswire/ -- PAVmed Inc. (NASDAQ:PAVM, PAVMZ)))

LUCD

3 minute read

PAVmed Shareholders As Of January 15, 2024 Will Participate In Distribution Of ~3.3M Shares Of Lucid Common Stock And Also Announces 1-For-15 Reverse Stock Split

By Benzinga Newsdesk

December 4, 5:29 PM

PAVmed shareholders as of January 15, 2024 will participate in distribution of approximately 3.3 million shares of Lucid common stock1-for-15 reverse stock split to be effective as of market open on December 7, 2023NEW

LUCD

3 minute read

Lucid Diagnostics Strengthens And Expands Market Access And Direct Contracting Efforts; Shaun M. O’Neil Promoted To Lucid’s President And COO

By Benzinga Newsdesk

November 16, 10:14 AM

Industry veterans join executive team as VP, Market Access and VP, Employer MarketsShaun M. O'Neil promoted to Lucid's President and COONEW YORK, Nov. 16, 2023 /PRNewswire/ -- Lucid Diagnostics

LUCD

8 minute read

Earnings

Earnings Scheduled For November 13, 2023

By Benzinga Insights

November 13, 7:40 AM

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.

AACG